Search
for
Sort by
Research 661–690 of 1000+
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- 5α-Reduced glucocorticoids: a story of natural selection
- Acute urinary retention: risks and management.
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Anabolic effects of testosterone are preserved during inhibition of 5α-reductase
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- An Update on Plant Derived Anti-Androgens
- Decreased fertility in male rats administered the 5α-reductase inhibitor, finasteride, is due to deficits in copulatory plug formation
- Recent advances in thiasteroids chemistry
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- Epitestosterone—an endogenous antiandrogen?
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise
- Does a male polycystic ovarian syndrome equivalent exist?
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Androgen antagonists in androgen target tissues
- Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
- Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Dutasteride for the treatment of benign prostatic hyperplasia